Clinical Observation Of Kangyi Capsule In Treatment Of Transient Ischemic Attack (Qi Deficiency And Blood Stasis Syndrome)

Objective :To observe the clinical efficacy and security of Kangyi Capsule in the treatment of transient ischemic attack of qi deficiency and blood stasis syndrome,as well as to evaluate clinical value of Kangyi Capsule and discuss the mechanisms of Kangyi Capsule in the treatment of transient ischemic attack of qi deficiency and blood stasis syndrome.Methods : Applied Stochastic Processes method of bins,the 74 patients were consisents with the diagnostic criteria of transient ischemic attack of qi deficiency and blood stasis syndrome were divided into control group and observation group inrandomization.The control group was given neurology department Western medicine therapy,the observation group on the basis of neurology department Western medicine therapy given Kangyi Capsule.Observe two groups of patients clinical curative effect,TCM syndrome integration,dysneuria extents were scored,Activities of daily living evaluation,During the clinical research,2 weeks for drug treatment,and after 3 months of follow-up time were included,the disease frequency of attacks,an assessment of the risk of final cerebral infarction,Statistical analysis of the numerical changes of various observation indexes.To evaluating the clinical efficacy of the two groups.Observed the blood routine,liver and kidney function,blood coagulation of the two groups of patients,to evaluating the safety of its clinical application.Results :1.The clinical efficacyof Kangyi Capsule in the treatment of transient ischemic attack of qi deficiency and blood stasis syndrome,The efficacy scores of both groups were significantly higher than before treatment,the effective of treatment for14 days is 94.6%,and the integralhe observation group was significantly higher than the control group(P<0.05).2.Two groups of patients treated with a course of treatment(14 days)were significantly lower than those before treatme,the change of observation group was significantly lower than that of control group(P<0.05).3.After 14 days of treatment,the scores of neurological defects were reduced in both groups,and the observation group decreased significantly compared with the control grou(P<0.05).4.For a course of treatment(14 days)after the ability compare two groups in the daily life,the observation group were improved,compared with more than in the control group before treatment and daily life ability score after treatment group increased more obviously than the control group(P<0.05).5.Two groups of patients were treated with a course of treatment(14 days)and the incidence of TIA in the patients after 3 months of follow-up.The observation group was lower than the control group(P<0.05).6.The blood routine,liver and kidney work,electrocardiogram and other safety indexes were normal before and after treatment,and no adverse events occurred during the treatment.Conclusion : Kangyi Capsule in Treatment of transient chemise attack(Qi Deficiency and Blood Stasis Syndrome)having satisfactory therapeutic effects.The result in the Prevent of stroke reduce the neurological deficit in TIA patients,improve TCM syndrome integration and the patient's daily life ability is significant and has high safety.